NM_025137.4:c.2066A>G
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 1P and 1B. PP3BP6
The NM_025137.4(SPG11):c.2066A>G(p.Glu689Gly) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000118 in 1,612,948 control chromosomes in the GnomAD database, with no homozygous occurrence. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E689K) has been classified as Uncertain significance.
Frequency
Consequence
NM_025137.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 11Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Illumina, G2P
- amyotrophic lateral sclerosis type 5Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Charcot-Marie-Tooth disease axonal type 2XInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
- juvenile amyotrophic lateral sclerosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_025137.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPG11 | NM_025137.4 | MANE Select | c.2066A>G | p.Glu689Gly | missense splice_region | Exon 10 of 40 | NP_079413.3 | ||
| SPG11 | NM_001411132.1 | c.2066A>G | p.Glu689Gly | missense splice_region | Exon 10 of 40 | NP_001398061.1 | |||
| SPG11 | NM_001160227.2 | c.2066A>G | p.Glu689Gly | missense splice_region | Exon 10 of 38 | NP_001153699.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPG11 | ENST00000261866.12 | TSL:1 MANE Select | c.2066A>G | p.Glu689Gly | missense splice_region | Exon 10 of 40 | ENSP00000261866.7 | ||
| SPG11 | ENST00000535302.6 | TSL:1 | c.2066A>G | p.Glu689Gly | missense splice_region | Exon 10 of 38 | ENSP00000445278.2 | ||
| SPG11 | ENST00000427534.6 | TSL:1 | c.2066A>G | p.Glu689Gly | missense splice_region | Exon 10 of 37 | ENSP00000396110.2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152238Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251070 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000822 AC: 12AN: 1460710Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 726754 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74378 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.2066A>G (p.E689G) alteration is located in exon 10 (coding exon 10) of the SPG11 gene. This alteration results from a A to G substitution at nucleotide position 2066, causing the glutamic acid (E) at amino acid position 689 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Hereditary spastic paraplegia 11 Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at